verve therapeutics stock price prediction

Sunday, July 3, 2022 Edit

Verve Therapeutics is a genetic medicines company pioneering a new approach to the care of cardiovascular disease transforming treatment from chronic management to single. During the day the.

Verve Therapeutics Inc Verv Stock Price Quote News Stock Analysis

Shares of Verve Therapeutics stock opened at.

. As of 2022 July 02. Verve Therapeutics Inc VERV gets an Overall Rank of 62 which is an above average rank under InvestorsObservers stock ranking system. Ad Biotech is becoming one of the best new sectors for investing if you know where to look.

Dow 30 Nasdaq Gold View all reports Verve Therapeutics Inc. Cambridge mass june 01 2022 globe newswire -- verve therapeutics a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene. And has now fallen 3 days in a row.

039 253 Apr 28 2022 400 PM EDT - Market open. Verve Therapeutics Inc Stock Price Forecast VERV Predictons for2021. It seems appropriate then that shares of biotech startup Verve.

In the short term 2weeks VERVs stock. Their VERV stock forecasts range from 3400 to 9200. We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value.

Primary metrics and data points about Verve Therapeutics Inc. Our latest prediction for Verve Therapeutics Incs stock price was made on the March 9 2022 when the stock price was at 2888. The current Verve Therapeutics VERV share price is 1690.

Verve Therapeutics Inc VERV Stock Forecasts By Institutional Analysts Verve Therapeutics Inc VERV Stock Earning Per Share EPS Forecast Estimate -0615 The average consensus EPS. 0 USD About the Verve Therapeutics Inc stock forecast Unlock SECRET Features HERE for 1. Stock Price Forecast The 7 analysts offering 12-month price forecasts for Verve Therapeutics Inc have a median target of 4800 with a high estimate of 7500 and a low estimate of 3400.

On average Wall Street analysts predict that VERVE THERAPEUTICS s share price could reach 5800 by Jun 17 2023. According to the issued ratings of 8 analysts in the last year the consensus rating for Verve Therapeutics stock is Moderate Buy based on the current 2 hold ratings and 6 buy. 8 brokerages have issued 12-month price targets for Verve Therapeutics shares.

Summary of all time highs changes and price drops for Verve Therapeutics. Find the latest Verve Therapeutics Inc VERV stock price forecast 12-month price target predictions and analyst recommendations. Stock Price Targets Yearly Numbers Estimates VERV will report 2022 earnings on 03132023 EPS Estimate 2021 2022 2023 2024 -5 -25 0 Quarterly Numbers Actuals Estimates VERV will report.

Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease. VERV IEX Real-Time Price USD. The forecast for the further price.

Ad FundVisualizer is a free powerful mutual fund comparison tool created for advisors. Verve Therapeutics Gets Off to a Fast Start The dictionary describes the word verve as having energy or vitality. Ad Were all about helping you get more from your money.

VERV stock forecast and price target Find the latest Verve Therapeutics Inc. This is 11 more than the trading day before Thursday 6th Jan 2022. The last closing price of the Verve Therapeutics Inc share was 1265 and has changed by 1355 since the penultimate trading day.

Modernas stock rose 28X in the past 2 years are these biotech picks next. Close price at the end of the last trading day Friday 7th Jan 2022 of the VERV stock was 3205. The average VERVE THERAPEUTICS stock price prediction forecasts.

VERV Price is 15650 USD today. Choose Investments Using 0 Online Stock and ETF Trades. Trade stocks bonds options ETFs and mutual funds all in one easy-to-manage account.

StockInvestus is a research service that provides financial data and technical analysis of publicly traded stocks. Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease. Here you can discuss everything related to VERV.

Stock price fell by -422 on the last day Tuesday 28th Jun 2022 from 1636 to 1567. 1 year Verve Therapeutics Forecast. The Score for VERV is 49 which is 2 below its historic median score of 50 and infers higher risk than normal.

The Verve Therapeutics Inc. On average they predict Verve. Use FundVisualizer to screen thousands of funds across 80 different performance metrics.

Lets get started today. Our system considers the. Ad Build Your Portfolio Your Way.

During the day the stock. Stifel Nicolaus decreased their target price on Verve Therapeutics from 5800 to 3400 in a report on Monday March 14th. Stock USD 1526 024 155 Verve Therapeutics stock price prediction is an act of determining the future value of Verve Therapeutics shares using few different conventional methods such.

We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value. VERV analyst stock forecast price target and.

Verve Therapeutics Inc Share Price Usd0 001

Verve Therapeutics Inc Verv Stock Price Quote News Stock Analysis

Verve Therapeutics Stock Forecast Down To 0 000001 Usd Verv Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis

Verve Therapeutics Nasdaqgs Verv Share Price News Analysis Simply Wall St